BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for Elecsys b-CrossLaps, Roche

Product group In-vitro diagnostics - immunological products
Reference 02400/13

Corrective action of Roche for Elecsys b-CrossLaps due to variation of sample stability and biotin inteference. Customers were informed accordingly.

Corrective action for Elecsys b-CrossLaps, Roche , Download_VeroeffentlichtAm_EN PDF, 98KB, File does not meet accessibility standards